跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,025 条关于
“Congenital Hyperinsulinism”
全部
3,025
临床试验
2,645
药物
29
机构
8
资讯
343
去年
Sidra Medicine Conducts First Clinical Trial for Pediatric Congenital Hyperinsulinism
9个月前
Rezolute's Ersodetug Fails Phase 3 Trial for Congenital Hyperinsulinism, Stock Plunges 88%
去年
Congenital Hyperinsulinism Pipeline Shows Promise with Multiple Therapies Advancing Through Clinical Development
去年
FDA Issues Second CRL for Dasiglucagon in Congenital Hyperinsulinism
9个月前
Rezolute's Phase 3 Trial for Congenital Hyperinsulinism Drug Fails to Meet Primary Endpoints
9天前
Rezolute's ersodetug Phase 3 sunRIZE misses primary endpoint in congenital hyperinsulinism; FDA review continues
去年
Ersodetug Receives FDA Breakthrough Therapy Designation for Congenital Hyperinsulinism
去年
FDA Lifts Clinical Holds on Rezolute's Ersodetug (RZ358) for Congenital Hyperinsulinism
2年前
FDA Lifts Clinical Hold on Rezolute's Ersodetug for Congenital Hyperinsulinism, Allowing US Trial Enrollment
2年前
FDA Issues Complete Response Letter for Dasiglucagon in Congenital Hyperinsulinism Due to Manufacturing Deficiencies
第 1 页,共 35 页
上一页
下一页